Taking people in Franciaország2. fázis
Phase 2, Open label Study of DS-1062a, an Anti-TROP-2-Antibody-Drug Conjugate (ADC), in patients with advanced and/or unresectable Non-Small Cell Lung Cancer (NSCLC), with biomarker analysis to characterize response to therapy_ ICARUS LUNG 01
Key facts
- Where
- Bordeaux, Brest, Caen Cedex 5, Créteil, Paris, Paris Cedex 20, Pierre-Bénite, Strasbourg Cedex és Villejuif, FranciaországSee the 9 sites
- Phase
- 2. fázis
Where in Franciaország
- Institut BergonieBordeaux, FranciaországTaking people
- Centre Hospitalier Régional et Universitaire de BrestBrest, FranciaországTaking people
- Centre Francois BaclesseCaen Cedex 5, FranciaországTaking people
- Centre Hospitalier Intercommunal de CréteilCréteil, FranciaországTaking people
- Hôpital CochinParis, FranciaországTaking people
- Hopital TenonParis Cedex 20, FranciaországTaking people
- Hospices Civils de LyonPierre-Bénite, FranciaországTaking people
- Les Hopitaux Universitaires De StrasbourgStrasbourg Cedex, FranciaországTaking people
- Institut Gustave RoussyVillejuif, FranciaországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut Gustave Roussy
- Trial code
- EU 2023-505924-71-00
- Record updated
- 2026. szeptember 18.